Cargando…
Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The International AIDS Society
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113030/ http://dx.doi.org/10.1186/1758-2652-13-S4-P29 |
_version_ | 1782205872126033920 |
---|---|
author | Schneider, L Houssaini, A Lambert, S Peytavin, G Agher, R Chermak, A Flandre, P Calvez, V Marcelin, AG Ghosn, J Katlama, C |
author_facet | Schneider, L Houssaini, A Lambert, S Peytavin, G Agher, R Chermak, A Flandre, P Calvez, V Marcelin, AG Ghosn, J Katlama, C |
author_sort | Schneider, L |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3113030 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | The International AIDS Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-31130302011-06-13 Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study Schneider, L Houssaini, A Lambert, S Peytavin, G Agher, R Chermak, A Flandre, P Calvez, V Marcelin, AG Ghosn, J Katlama, C J Int AIDS Soc Poster Presentation The International AIDS Society 2010-11-08 /pmc/articles/PMC3113030/ http://dx.doi.org/10.1186/1758-2652-13-S4-P29 Text en Copyright ©2010 Schneider et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Poster Presentation Schneider, L Houssaini, A Lambert, S Peytavin, G Agher, R Chermak, A Flandre, P Calvez, V Marcelin, AG Ghosn, J Katlama, C Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study |
title | Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study |
title_full | Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study |
title_fullStr | Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study |
title_full_unstemmed | Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study |
title_short | Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study |
title_sort | week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced hiv-1 patients with virological success: dardar study |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113030/ http://dx.doi.org/10.1186/1758-2652-13-S4-P29 |
work_keys_str_mv | AT schneiderl week48efficacyof900100mgdailyofdarunavirritonavirintreatmentexperiencedhiv1patientswithvirologicalsuccessdardarstudy AT houssainia week48efficacyof900100mgdailyofdarunavirritonavirintreatmentexperiencedhiv1patientswithvirologicalsuccessdardarstudy AT lamberts week48efficacyof900100mgdailyofdarunavirritonavirintreatmentexperiencedhiv1patientswithvirologicalsuccessdardarstudy AT peytaving week48efficacyof900100mgdailyofdarunavirritonavirintreatmentexperiencedhiv1patientswithvirologicalsuccessdardarstudy AT agherr week48efficacyof900100mgdailyofdarunavirritonavirintreatmentexperiencedhiv1patientswithvirologicalsuccessdardarstudy AT chermaka week48efficacyof900100mgdailyofdarunavirritonavirintreatmentexperiencedhiv1patientswithvirologicalsuccessdardarstudy AT flandrep week48efficacyof900100mgdailyofdarunavirritonavirintreatmentexperiencedhiv1patientswithvirologicalsuccessdardarstudy AT calvezv week48efficacyof900100mgdailyofdarunavirritonavirintreatmentexperiencedhiv1patientswithvirologicalsuccessdardarstudy AT marcelinag week48efficacyof900100mgdailyofdarunavirritonavirintreatmentexperiencedhiv1patientswithvirologicalsuccessdardarstudy AT ghosnj week48efficacyof900100mgdailyofdarunavirritonavirintreatmentexperiencedhiv1patientswithvirologicalsuccessdardarstudy AT katlamac week48efficacyof900100mgdailyofdarunavirritonavirintreatmentexperiencedhiv1patientswithvirologicalsuccessdardarstudy |